Komori
Press Kogyo (7246) · RiskMitigated

Market Price Risk on Investment Securities

First written in FY2017. 13 of 27 entries say "Mitigated", first in FY2020-Q3. Latest entry: FY2026.

27entries
10years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017 – FY2018MitigatedFY2021-Q1 – FY2022-Q32017: 120172018: 120182019: 420192020: 420202021: 320212022: 320222023: 420232024: 320242025: 220252026: 22026
Same theme, other companies
Risk from fluctuations in the market prices of financial instruments heldA theme 316 companies write about · 315 as a headwind · 2 as a tailwind

The whole theme swung hardest in 2019: 53 of 135 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 319 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026MitigatedAnnual report

    「The balance of valuation differences on other securities increased from ¥3,273 million at the end of the previous fiscal year to ¥3,615 million, resulting in a positive ¥341 million in other comprehensive income for the fiscal year.」

    Both the balance of valuation differences on other securities and the valuation difference for the year improved, recovering from the negative valuation difference caused by market price movements.
  2. 2026-05-15MitigatedEarnings

    「The valuation difference on other securities increased from ¥3,273 million to ¥3,615 million.」

    The balance of the valuation difference on other securities increased from the end of the previous fiscal year.
  3. FY2026-H1WorsenedAnnual report

    「Valuation differences on other securities - 273 Valuation differences on other securities 3,273 3,000」

    Valuation differences on other securities for the interim consolidated accounting period amounted to a negative ¥273 million, while the balance decreased from ¥3,273 million at the end of the previous fiscal year to ¥3,000 million.
  4. FY2025Valuation differences on securities decreasedAnnual report

    「The balance of valuation differences on other securities decreased from ¥3,551 million at the end of the previous fiscal year to ¥3,273 million, resulting in a negative ¥278 million in other comprehensive income for the fiscal year.」

    The balance of valuation differences on investment securities decreased, and other comprehensive income for the year also included a negative ¥278 million.
  5. FY2025-H1WorsenedAnnual report

    「Valuation differences on other securities 992 - 417 Valuation differences on other securities 3,551 3,133」

    Valuation differences on other securities turned from a positive ¥992 million in the same period of the previous year to a negative ¥417 million, while the balance decreased from ¥3,551 million to ¥3,133 million.
  6. FY2024MitigatedAnnual report

    「The balance of valuation differences on other securities increased from ¥2,219 million at the end of the previous fiscal year to ¥3,551 million, resulting in a positive ¥1,332 million in other comprehensive income for the fiscal year.」

    Both the balance of valuation differences on securities and the valuation difference for the period improved from the previous year, with the positive valuation difference resulting from market price movements increasing.
  7. FY2024-Q3The positive valuation difference on securities narrowed from the end of the previous quarter.Annual report

    「Valuation difference on available-for-sale securities △ 34 929 Valuation difference on available-for-sale securities 2,219 3,148」

    The valuation difference on available-for-sale securities improved from negative ¥34 million in the same period of the previous year to ¥929 million, while the balance on the balance sheet decreased slightly from ¥3,211 million at the end of the previous quarter to ¥3,148 million.
  8. FY2024-Q2MitigatedAnnual report

    「Valuation difference on available-for-sale securities 106 992 Valuation difference on available-for-sale securities 2,219 3,211」

    The valuation difference on available-for-sale securities for the quarter-to-date period increased from ¥106 million in the same period of the previous year to ¥992 million, and the balance also increased from ¥2,219 million to ¥3,211 million.
  9. FY2024-Q1MitigatedAnnual report

    「Valuation difference on available-for-sale securities △ 233 567」

    The valuation difference on available-for-sale securities for the three-month period improved from negative ¥233 million in the same period of the previous year to ¥567 million. The balance on the balance sheet also increased from ¥2,219 million to ¥2,786 million.
  10. FY2023MitigatedAnnual report

    「Valuation difference on available-for-sale securities 2,192 2,219」

    The balance of the valuation difference on available-for-sale securities increased from ¥2,192 million at the end of the previous fiscal year to ¥2,219 million, and the valuation difference on available-for-sale securities for the current period was also positive at ¥26 million.
  11. FY2023-Q3WorsenedAnnual report

    「Valuation difference on available-for-sale securities 377 △ 34 Impairment loss on investment securities － 154」

    The valuation difference on available-for-sale securities for the nine-month period changed from ¥377 million in the same period of the previous year to negative ¥34 million, and an impairment loss on investment securities of ¥154 million was also recognized.
  12. FY2023-Q2WorsenedAnnual report

    「Impairment loss on investment securities － 151 Valuation difference on available-for-sale securities 557 106 Valuation difference on available-for-sale securities 2,192 2,298」

    Although the balance of the valuation difference on available-for-sale securities increased, the valuation difference for the quarter-to-date period narrowed from ¥557 million in the same period of the previous year to ¥106 million, and an impairment loss on investment securities of ¥151 million was also recognized.
  13. FY2023-Q1WorsenedAnnual report

    「Valuation difference on available-for-sale securities 620 △ 233 Valuation difference on available-for-sale securities 2,192 1,959」

    The valuation difference on available-for-sale securities for the quarter-to-date period changed from ¥620 million in the same period of the previous year to negative ¥233 million, and the balance also decreased from ¥2,192 million to ¥1,959 million.
  14. FY2022-Q3MitigatedAnnual report

    「Valuation difference on available-for-sale securities 1,561 1,938」

    The balance of the valuation difference on available-for-sale securities increased from ¥1,561 million at the end of the previous fiscal year to ¥1,938 million.
  15. FY2022-Q2MitigatedAnnual report

    「Valuation difference on available-for-sale securities　¥457 million　¥557 million」

    The valuation difference on available-for-sale securities increased from ¥457 million in the same period of the previous year to ¥557 million, with no negative impact from the valuation difference during the six-month period. The balance on the balance sheet also increased from ¥1,561 million at the end of the previous fiscal year to ¥2,118 million.
  16. FY2022-Q1MitigatedAnnual report

    「Valuation difference on available-for-sale securities 1,561 2,181 Valuation difference on available-for-sale securities 690 620」

    The balance of the valuation difference on available-for-sale securities increased from ¥1,561 million at the end of the previous fiscal year to ¥2,181 million, while the valuation difference for the six-month period decreased from ¥690 million in the same period of the previous year to ¥620 million.
  17. FY2021-Q3MitigatedAnnual report

    「Valuation difference on available-for-sale securities △ 340 817 Valuation difference on available-for-sale securities 161 978」

    The valuation difference on available-for-sale securities for the nine-month period improved from negative ¥340 million in the same period of the previous year to ¥817 million. The balance on the balance sheet also increased from ¥161 million at the end of the previous consolidated fiscal year to ¥978 million.
  18. FY2021-Q2MitigatedAnnual report

    「Valuation difference on available-for-sale securities　negative ¥829 million　¥457 million」

    The valuation difference on available-for-sale securities improved from negative ¥829 million in the same period of the previous year to ¥457 million in the current period, indicating an improvement in the valuation difference for the six-month period.
  19. FY2021-Q1MitigatedAnnual report

    「Valuation difference on available-for-sale securities 161 851」

    The balance of the valuation difference on available-for-sale securities increased from ¥161 million at the end of the previous consolidated fiscal year to ¥851 million.
  20. FY2020WorsenedAnnual report

    「The valuation difference on available-for-sale securities decreased from ¥2,319 million in the previous consolidated fiscal year to ¥161 million. In the current consolidated fiscal year, an impairment loss of ¥91 million was recognized on available-for-sale securities.」

    The balance of the valuation difference on available-for-sale securities declined significantly, and an impairment loss of ¥91 million was also recognized, worsening the impact of market price fluctuations.
  21. FY2020-Q3MitigatedAnnual report

    「Valuation difference on available-for-sale securities △ 898 △ 340 Valuation difference on available-for-sale securities 2,319 1,979」

    The valuation difference on available-for-sale securities for the nine-month period was negative ¥340 million, narrowing the loss from negative ¥898 million in the same period of the previous year. The balance on the balance sheet was ¥1,979 million, below the ¥2,319 million at the end of the previous consolidated fiscal year.
  22. FY2020-Q2WorsenedAnnual report

    「Valuation difference on available-for-sale securities 126 △ 829 Valuation difference on available-for-sale securities 2,319 1,489」

    The valuation difference on available-for-sale securities for the six-month period was negative ¥829 million, compared with ¥126 million in the same period of the previous year. The balance on the balance sheet also decreased from ¥2,319 million to ¥1,489 million.
  23. FY2020-Q1WorsenedAnnual report

    「Valuation difference on available-for-sale securities 2,319 1,668」

    The balance of the valuation difference on available-for-sale securities decreased from ¥2,319 million at the end of the previous consolidated fiscal year to ¥1,668 million. In addition, the valuation difference on available-for-sale securities for the quarter was negative ¥651 million, narrowing the positive valuation difference arising from market price fluctuations.
  24. FY2019The positive valuation difference on securities narrowed.Annual report

    「Valuation difference on available-for-sale securities 3,304 2,319」

    The balance of the valuation difference on available-for-sale securities decreased from ¥3,304 million to ¥2,319 million, narrowing the positive valuation difference.
  25. FY2019-Q3WorsenedAnnual report

    「Other comprehensive income Valuation difference on available-for-sale securities △ 898 1,440」

    The valuation difference on available-for-sale securities changed from ¥1,440 million in the same period of the previous year to negative ¥898 million, with the valuation difference arising from market price fluctuations moving from positive to negative.
  26. FY2018RestatedAnnual report

    「Investment securities are exposed to the risk of fluctuations in market prices.」

    The risk of fluctuations in the market prices of investment securities remains.
  27. FY2017First statedAnnual report

    「Investment securities are exposed to the risk of fluctuations in market prices.」

    The disclosure indicates the risk of fluctuations in the market prices of investment securities.
Moved together

"Profit distribution with a medium-term target of a 20% consolidated dividend payout ratio" moved the same way as this thread, in the same document, in 8 of its 27 moves.

877655★123456
  1. ★This thread
  2. 1Profit distribution with a medium-term target of a 20% consolidated dividend payout ratio8×
  3. 2Segment profitability in the automotive and construction equipment businesses7×
  4. 3Increase in Cash Generation from Operating Activities7×
  5. 4Operating Profit Rises Despite Declining Sales6×
  6. 5Indonesia’s Currency Depreciation, High Interest Rates and Sluggish Resource Prices5×
  7. 6Improving the Financial Position and Cash Flow Through Interest-Bearing Debt Reduction and Securing Business Earnings5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Press Kogyo yet. It last moved in the Earnings of 2026-05-15: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Market Price Risk on Investment Securities | PRESS KOGYO CO.,LTD. (7246) | Komori